SDAX

EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda

Retrieved on: 
Wednesday, April 10, 2024
Annual, EUR, Supervisory board, Frankfurt Stock Exchange, CFO, DAX, Election, Messenger, SDAX, Bank statement, Annual general meeting, SCHOTT, Fine chemical

EQS-News: SCHOTT Pharma AG & Co. KGaA

Key Points: 
  • EQS-News: SCHOTT Pharma AG & Co. KGaA
    Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
    The issuer is solely responsible for the content of this announcement.
  • Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
    SCHOTT Pharma's first Annual General Meeting was held virtually on March 14, 2024
    SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, held its first Annual General Meeting today.
  • The Annual General Meeting took place virtually and allowed shareholders to interact directly and ask questions to the Management Board and Supervisory Board.
  • “Holding our first Annual General Meeting marks the next milestone in our capital market history.

EQS-News: Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB

Retrieved on: 
Wednesday, April 10, 2024
EUR, Holding company, Supervisory board, Frankfurt Stock Exchange, Acquisition, SDAX, Goods, Regulated market, MUX, HQ, Porcelain

Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB

Key Points: 
  • Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB
    The issuer is solely responsible for the content of this announcement.
  • Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB
    Munich, April 10, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB.
  • In business since 1961 and 1949 respectively, Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. are among the leading providers of electrical power engineering services in Poland with revenues of approx.
  • Robin Laik, CEO of Mutares, comments: "With the acquisition of Eltel Networks Energetyka and Eltel Networks Engineering, we are signing our first transaction in Poland strengthening our Goods & Services segment in the field of electrical power engineering & construction services.

EQS-News: CEO Markus Lesser will be leaving PNE AG at the end of July

Retrieved on: 
Wednesday, April 10, 2024
Employment, IPP, Farm, Growth, Supervisory board, TecDAX, Supervision, PNE AG, Cuxhaven, Wind, SDAX, PNE

Cuxhaven, March 15 – Markus Lesser, CEO of PNE AG, today informed the Supervisory Board of his intention to resign from his postion as member and Chairman of the Board of Management of PNE AG with effect from the end of July 2024 for personal reasons.

Key Points: 
  • Cuxhaven, March 15 – Markus Lesser, CEO of PNE AG, today informed the Supervisory Board of his intention to resign from his postion as member and Chairman of the Board of Management of PNE AG with effect from the end of July 2024 for personal reasons.
  • At the same time, the Supervisory Board will endeavour to find a suitable successor candidate for the position of CEO.
  • Per Hornung Pedersen, Chairman of the Supervisory Board: "We very much regret that Markus Lesser has decided to take this step.
  • After starting at PNE as COO in 2011, he was appointed CEO in 2016 following a number of successful years.

EQS-News: CEWE is planning further turnover and earnings growth in 2024

Retrieved on: 
Wednesday, April 10, 2024
Online, Retail, Annual, Conference, EBT, Supervisory board, Growth, Economic development, Commercial, SDAX, ROCE, Annual report, Marketing

The targets for 2023 have thus clearly been achieved: CEWE had planned Group turnover in the range of 720 to 780 million euros and EBIT of up to 82 million euros for 2023.

Key Points: 
  • The targets for 2023 have thus clearly been achieved: CEWE had planned Group turnover in the range of 720 to 780 million euros and EBIT of up to 82 million euros for 2023.
  • CEWE is also planning further growth for the 2024 financial year: Group turnover is expected to reach a value in the range of 770 to 820 million euros in 2024, while Group EBIT is expected to be in the corridor of 77 to 87 million euros.
  • Turnover in the core business segment of Photofinishing rose significantly by 42.7 million euros or +6.9% to 658.8 million euros in 2023 (photofinishing turnover in 2022: 616.1 million euros).
  • Group turnover is expected to be in the range of EUR 770 million to EUR 820 million in 2024.

EQS-News: KSB closes the 2023 financial year with record performance

Retrieved on: 
Wednesday, April 10, 2024
Annual, Growth, Supervisory board, Management, SDAX, News, Frankenthal, Workforce, Mission, Income tax, KSB, Marketing, Security (finance)

FRANKENTHAL: Frankenthal-based pump and valve manufacturer KSB closed the 2023 financial year with record figures for order intake and sales revenue.

Key Points: 
  • FRANKENTHAL: Frankenthal-based pump and valve manufacturer KSB closed the 2023 financial year with record figures for order intake and sales revenue.
  • In the 2023 financial year, KSB significantly increased order intake by + 3.4 % to € 2,960 million.
  • KSB increased sales revenue by + 9.5 % to € 2,819 million in the 2023 financial year.
  • The KSB shareholders are to participate to a particular extent in the record performance achieved for the 2023 financial year.

EQS-News: Second acquisition in 2024: Mutares has signed an agreement for the transfer of Magirus from Iveco Group

Retrieved on: 
Wednesday, April 10, 2024
EXM, EUR, Growth, Supervisory board, Frankfurt Stock Exchange, Iveco, CFO, Acquisition, SDAX, Goods, IVG, Airport, Regulated market, MUX, HQ

Munich, March 13, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has signed an agreement for the transfer of Magirus from Iveco Group (EXM: IVG).

Key Points: 
  • Munich, March 13, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has signed an agreement for the transfer of Magirus from Iveco Group (EXM: IVG).
  • Due to the required unbundling measures, the transaction is expected to be completed no later than January 2025.
  • Mark Friedrich, CFO of Mutares, comments on the transaction: “Magirus is a typical Mutares acquisition where the company stands for a reputed brand with high quality and represents a compelling value proposition.
  • As the portfolio grows, so do consulting revenues, which together with portfolio dividends and exit proceeds accrue to the Mutares Holding.

EQS-News: CEWE increases dividend for fifteenth consecutive year

Retrieved on: 
Wednesday, April 10, 2024
Annual, Conference, Supervisory board, Goldman Sachs, Supervision, Management, Android, SDAX, Publication, Holding company

Oldenburg, 19 March 2024.

Key Points: 
  • Oldenburg, 19 March 2024.
  • The Supervisory Board of CEWE Stiftung & Co. KGaA (SDAX, ISIN: DE 0005403901) decided with its meeting today to propose the fifteenth consecutive dividend increase.
  • CEWE thus further strengthens its position among the top 3 of the 644 listed German companies that have continuously increased their dividends over so many years.
  • : 0441 / 404 - 552, Fax: 0441 / 404 - 421, Email: [email protected]
    The CEWE apps are all available in the app stores: CEWE PHOTO WORLD, CEWE POSTCARD and other photo apps, and the CEWE Investor Relations app for iPad© or android tablets, with annual reports and quarterly reports, presentations and sustainability reports.

EQS-News: AI specialist strengthens INDUS portfolio

Retrieved on: 
Wednesday, April 10, 2024
Automation, Assembly, Growth, Artificial intelligence, Acquisition, Robotics, AI, Engineering, SDAX, Herman Kelly and Life, Medical device

Bergisch Gladbach, 14 March 2024 – SDAX-listed investment company INDUS Holding AG has acquired Gestalt Robotics.

Key Points: 
  • Bergisch Gladbach, 14 March 2024 – SDAX-listed investment company INDUS Holding AG has acquired Gestalt Robotics.
  • Its portfolio of solutions comprises image processing and control technology based on artificial intelligence.
  • The acquisition thus supports our strategic initiative ‘Driving innovation’, which, among other things, promotes the rapid implementation of AI solutions in our portfolio companies.”
    Thomas Staufenbiel and Prof. Dr.-Ing.
  • “Gestalt Robotics’ focus on industrial automation complements our investment portfolio in the Engineering segment very well,” says Axel Meyer, Board member of INDUS Holding AG responsible for the Engineering segment.

EQS-News: Mutares with successful fiscal year 2023: Net income of Mutares Holding increases to EUR 102.5 million – dividend of EUR 2.25 per share planned

Retrieved on: 
Wednesday, April 10, 2024
Annual, Tax, Holding company, Growth, Supervisory board, Frankfurt Stock Exchange, Policy, Acquisition, Sale, SDAX, SMP, Investment, Annual report, Mutares, Mobility, Depreciation, Regulated market, MUX, Service, HQ, Film industry

Mutares with successful fiscal year 2023: Net income of Mutares Holding increases to EUR 102.5 million – dividend of EUR 2.25 per share planned

Key Points: 
  • Mutares with successful fiscal year 2023: Net income of Mutares Holding increases to EUR 102.5 million – dividend of EUR 2.25 per share planned
    The issuer is solely responsible for the content of this announcement.
  • The net income of Mutares Holding for the fiscal year 2023 increased to EUR 102.5 million, compared with EUR 72.9 million in the previous year.
  • The Mutares Group generated revenues of EUR 4,689.1 million in the fiscal year 2023 (previous year: EUR 3,751.7 million).
  • Accordingly, net income in the Holding Company is expected to be in the range of EUR 125 million to EUR 150 million for the fiscal year 2025 and EUR 200 million for the fiscal year 2028.

RLS Radiopharmacies Partners with Eckert & Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

Retrieved on: 
Thursday, April 4, 2024
Oncology, Medical Devices, Health, Radiology, Pharmaceutical, Biotechnology, Gallium, Diagnosis, Radionuclide, Glomus tumor, Prostate cancer, USP, Half-life, Actinium-225, Partnership, Patient, Pharmacy, RLS, PET, Splenic infarction, Cancer, SDAX, Radiopharmaceutical, Investment, Cyclotron, ISO, Positron emission tomography, DSM-IV codes, Gelastic seizure, Medical imaging

Under the partnership, all 31 of RLS’s radiopharmacies will be equipped with Eckert & Ziegler’s advanced GalliaPharm® generators, which the radiopharmacy network will utilize to produce high-quality, life-enhancing Gallium-68-based (Ga-68) radiopharmaceuticals.

Key Points: 
  • Under the partnership, all 31 of RLS’s radiopharmacies will be equipped with Eckert & Ziegler’s advanced GalliaPharm® generators, which the radiopharmacy network will utilize to produce high-quality, life-enhancing Gallium-68-based (Ga-68) radiopharmaceuticals.
  • “A powerful diagnostic isotope, Gallium has an extremely short half-life, necessitating the need for Ga-68-based radiopharmaceuticals to be produced within minutes of patient dosing.
  • This signifies a major leap forward in our commitment to advancing healthcare and improving patient outcomes through cutting-edge radiopharmaceuticals."
  • To date, RLS has installed Eckert & Ziegler’s GalliaPharm® generators within most of its locations and anticipates the remaining radiopharmacies will be operational by the end of June.